Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
David Sheyn · NCT06096597
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2, Phase 3
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- July 24, 2024
- Record last updated
- September 4, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Interstitial cystitis/painful bladder syndrome (IC/PBS) is a clinical syndrome in which patients report symptoms of bladder and/or pelvic pain with pressure and/ or discomfort associated with urinary frequency and urgency.
The primary objective of this study is to determine the efficacy of amniotic membrane therapy in patients with interstitial cystitis/painful bladder syndrome (IC/PBS) as defined by clinically-significant improvement in validated symptom questionnaires.
Being studied: Clarix Flo; Placebo
Conditions: Interstitial Cystitis; Painful Bladder Syndrome; Painful Bladder Syndrome (PBS)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patients 18 years of age or older
- Female
- English Speaking
- Diagnosis of IC/PBS
- Have failed at least one prior treatment for IC/PBS
Exclusion Criteria
- Patients less than 18 years of age
- Unable to provide consent
- Non-English speaking
- Patients with known anatomical malformations of the ureters, bladder, or urethra
Recruiting US locations
University Hospitals
Clevleand, OH 44106
Site contact: Diana Mitchell, MD · (216) 844-3009 · diana.mitchell@uhhospital.org
Study contacts (from the official record)
- Diana Mitchell, MD · (216) 844-3009 · diana.mitchell@uhhospitals.org
- David Sheyn, MD · David.Sheyn@uhhospitals.org
Similar studies in Ohio
All healthy volunteers studies in Ohio →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Hanmi Pharmaceutical Company Limited
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
LH-001 vs Placebo in Healthy Participants
Chien-Liang Lin
- Location
- Columbus, OH
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Beachwood, OH + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Columbus, OH + 9 other US sites
- Eligibility basics
- Ages 50–75